Adam Scott Bristol

Dr. Adam S.
Bristol is a Director of Investments at Aquilo Capital Management LLC.
He joined Aquilo in January 2010.
Prior to joining Aquilo, he served as an Associate at the Biotechology Value Fund, assisting in sourcing and evaluating private and public biotechnology companies.
He is an Advisor to the Michael J.
Fox Foundation for Parkinson’s Research.
He is a Class 14 Kauffman Fellow and was formerly on the Board of Directors of Airmid and Viriome Inc. He was a postdoctoral fellow in Neurobiology at Stanford University’s School of Medicine and has a Ph.
D.
from Yale University.